Amicus - C SPRL
0.8 FTEThe score of Amicus - C shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -44 % Total assets +43 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Amicus - C's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 28 Apr 2026
- Year ended 30 Sep 2024filed on 19 May 2025
- Year ended 30 Sep 2023filed on 30 Apr 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 29 Apr 2022
Amicus - C's financial analysis
- Solvency8.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Amicus - C
Amicus - C's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0464.271.001
- VAT number
- BE0464271001
- Peppol
- Registered · 0208:0464271001 · as of 08 Nov 2026
- Legal form
- SPRL
- Incorporated
- 02 Oct 1998
- Registered office
- 2600 Antwerp
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 28 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Amicus - C (SPRL) has been based in Antwerp since 1998, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 113,639 € and equity of 135,180 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 8.5%, below the median of its sector (44.2%).
Companies similar to Amicus - C
Companies in the same business, of comparable size and area, outside its group.
- Geassocieerde Apotheek Markgrave Retail sale of pharmaceutical products Antwerp · balance sheet €1.56m
- Apotheek Zaghbour Retail sale of pharmaceutical products Antwerp · balance sheet €1.62m
- Decaphar Retail sale of pharmaceutical products Oudenaarde · balance sheet €1.58m
- Pharmacie DE LA Porte DE Ghlin Retail sale of pharmaceutical products Mons · balance sheet €1.59m
- Liephar Retail sale of pharmaceutical products Mettet · balance sheet €1.59m
- Heerse Apotheek Retail sale of pharmaceutical products Heers · balance sheet €1.57m
- Soliena Retail sale of pharmaceutical products Buggenhout · balance sheet €1.57m
- Dekerk Kumtich Retail sale of pharmaceutical products Tienen · balance sheet €1.60m
Frequently asked questions about Amicus - C
What is the revenue of Amicus - C?
Amicus - C files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Amicus - C?
In Belgium, the VAT number is the company number prefixed with BE: BE0464271001 for Amicus - C, if the company is VAT-registered. Its company number (CBE) is 0464.271.001.
Where is the registered office of Amicus - C?
According to the CBE register, the registered office of Amicus - C is in 2600 Antwerp.
What is the equity of Amicus - C?
At the close of the 2025 financial year, the equity of Amicus - C amounts to 135,180 €, a solvency of 8.5% of total assets.
How many people work at Amicus - C?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Amicus - C?
The register lists 2 active mandates at Amicus - C. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Amicus - C
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →